This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a quasi-experimental design? a. ex post facto b. multiple time series ... (Read 63 times)

james9437

  • Hero Member
  • *****
  • Posts: 568
Which of the following is a quasi-experimental design?
 
  a. ex post facto
  b. multiple time series
  c. nonequivalent before-after
  d. all of these

Question 2

The nonequivalent before-after design controls for ____ but not for ____.
 
  a. history; maturation
  b. history; selection-maturation
  c. maturation; history
  d. selection-maturation; the Hawthorne effect



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yifu223

  • Sr. Member
  • ****
  • Posts: 302
Answer to Question 1

D

Answer to Question 2

B




james9437

  • Member
  • Posts: 568
Reply 2 on: Jun 20, 2018
Gracias!


zacnyjessica

  • Member
  • Posts: 345
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The liver is the only organ that has the ability to regenerate itself after certain types of damage. As much as 25% of the liver can be removed, and it will still regenerate back to its original shape and size. However, the liver cannot regenerate after severe damage caused by alcohol.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library